Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LS1081, "A Pilot Study of Dendritic Cell Therapy Delivered Intratumorally After Cryoablation or Intradermally for Patients With B-Cell Non-Hodgkin's Lymphoma"

NCT01239875 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT01239875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01239875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LS1081, "A Pilot Study of Dendritic Cell Therapy Delivered Intratumorally After Cryoablation or Intradermally for Patients With B-Cell Non-Hodgkin's Lymphoma"
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2010
Completion date
July 17, 2019
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult diffuse mixed cell lymphoma, adult diffuse small cleaved cell lymphoma, adult grade iii lymphomatoid granulomatosis, adult immunoblastic large cell lymphoma, adult lymphoblastic lymphoma, cutaneous b-cell non-hodgkin lymphoma, extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue, grade 1 follicular lymphoma, grade 2 follicular lymphoma, grade 3 follicular lymphoma, mantle cell lymphoma, marginal zone lymphoma, nodal marginal zone b-cell lymphoma, small lymphocytic lymphoma, splenic marginal zone lymphoma, waldenstrom macroglobulinemia with nodal disease